Turkish Journal of Cancer Research

About Journal

Focus and Scope
The Journal is scientific publication of Academician Publishing. It is a medical academic journal, being published four times a year and peer-reviewed. The Journal aims to publish original contributions based on clinical or experimental studies in the fields of Basic and Clinical Oncology, Hematology, Radiation Oncology, Surgical Oncology, Gynecological Oncology, Radiology and Nuclear Medicine. The scientific language of the journal is English.
Turkish Journal of Cancer Research publishes:

Original researches

Case reports

Editorial comments

Reviews

Letters to the editor

Subject areas include but are not restricted to the following fields:

Basic and Clinical Oncology

Hematology

Radiation Oncology

Surgical Oncology

Gynecological Oncology

Radiology

Nuclear Medicine

The journal covers all relevant branches in basic sciences besides the surgical and non-surgical specialties of the topics mentioned above.

Review Policy
Initial Manuscript Evaluation
For consideration, all manuscripts should be submitted by online system of The Journal at https://www.cancer-research.net. The whole editorial process of The Journal is done via online submission system, and can be documented in case of a conflict or objection.
The suitability of papers for publication in The Journal is decided by the editorial policy of the editorial board.
Editor-in-Chief is fully authorized for reviewing process, which is processed in the order of submission to The Journal.
Editor-in-Chief assigns either one of the Co-Editors or himself in order to perform initial assessment. Then, the assignee conducts initial pre-refereeing checks to ensure the article is legible, complete, correctly formatted, original, within the scope of The Journal, in the style of a scientific article and written in clear language.
Check for Plagiarism
Academician Publishing is a member of Crosscheck, and all manuscripts are screened in terms of originality. If serious issues are identified concerning the manuscript, the assignee will notify the corresponding author as part of our standard procedure. No action is required from you unless specifically requested for very serious concerns.
Any article that has problems with any of the above criteria may be rejected at this stage. Manuscripts rejected at this stage typically are not in line with the focus and scopes of the journal. Essays that pass through this stage are then entered into the peer review process.
This journal follows a double-blind reviewing procedure. Authors are therefore requested to submit:
1. A blinded manuscript file without any author names and affiliations in the text. Self-identifying citations and references in the article text should be avoided.
2. A separate full manuscript file, containing title, all author names, affiliations, ORCID iDs, contact information of the corresponding author and all other components of the manuscript. Any acknowledgements, disclosures, or funding information should also be included on this page.
Editorial Assistants at The Journal facilitate the peer review process by assisting with blinding manuscripts and corresponding with potential peer reviewers.
The Journal adheres to a strict policy of double-blind, peer-review to ensure best practices in scholarly research and publication. In Double-blind model, the reviewers do not know the names of the authors, and the authors do not know who reviewed their manuscript. To ensure anonymity in the double-blind refereeing process, the author's name should not appear anywhere on the manuscript. If using Microsoft Word the manuscript 'Summary', under the menu 'File/Properties/Summary', should also be erased. Once blinded, the assignee selects at least two members of the advisory board, and manuscripts are shared with these experts within the field for double-blind peer review, in which both the Reviewer and the Author remain anonymous throughout the process. A reviewer may not belong to the same institution as authors.
After assigned, the reviewers are invited to participate the review process via a notification email. The email invitation to reviewers will contain all necessary information about the manuscript. The reviewers are asked to log into the journal web site to indicate whether they will undertake the review or not, as well as to access the submission and to record their review and recommendation.
Automated email reminders are sent to the reviewer when the reviewer does not respond to a review request within 7 days. The typical period of time allowed for reviews is 4 weeks but note that it can be modified during the editorial process.
Peer Review Reports
Reviewers make one of the following recommendations to the Editors: accept submission, revisions required, resubmit for review, resubmit elsewhere, decline submission. Additionally, reviewers are asked to provide significant commentary for authors and are also provided space to make comments intended solely for the editors. Reviewers are not asked or expected to make any copyediting comments.
If both reviewers agree on acceptance or rejection, the decision stands.
Occasionally, we receive contradicting Reviewers' reports and need to ask for a third reviewer, which does delay the process. When their opinions are poles apart, then the Associate Editor takes a further process to decide acceptance or rejection of that paper. For the further process, Associate Editors request an emergency review by another advisory board member. Associate Editors may take a further process for the manuscript of which reviewing process is overdue.
If a paper is not suitable for publication it will be returned to the author with a statement of reasons for rejection. The author may appeal if he or she believes an erroneous or unfair judgment has been made. A letter to the Editor-in-Chief presenting reasons why the decision should be reconsidered will be subjected to due consideration.
After review, the author is notified by email for revision in accord with suggestions made by the reviewers and the Editor.
At the completion of each round of the peer review process, the submitter receives a formal letter from the Editor that includes notes from the Peer Reviewers.
When authors make revisions to their article in response to the referees' comments they are asked to submit a list of changes and any replies for transmission to the referees. The author must upload the revised manuscript to the online system within 4 weeks; otherwise the author will be notified that the paper will be considered withdrawn.
The revised version is usually returned to at least one of the original reviewers who is then asked whether the revisions are satisfactory. If the referees remain dissatisfied, the paper can be referred to the advisory board of the journal for further consideration.
The assignee then, will check if the manuscript is revised as suggested by editorial members and proceed to the next step. If the assignee finds the revisions satisfying, then he or she will record the decision to accomplish the review process and reach final decision.
Decision Making Process
Based upon two or more reviewers' reports, the Co-Editors are responsible for making the decision regarding acceptance or rejection each essay and for communicating this decision to the submitter. At the completion of the peer review process, each submitter receives a formal letter from the Editors that includes notes from the Peer Reviewers.
The final decision by Editor-in-Chief is then made after all revisions were completed.
Authors are notified by e-mail when a manuscript has or has not been accepted for publication. Proofs of accepted manuscripts are sent to the author for correction within 4 weeks after acceptance. They should be proofread carefully according to the instructions attached and returned within the considered period. Authors will be charged for major corrections to their proofs.

Publication Frequency
Turkish Journal of Cancer Research publishes four issues per year online. The scientific language of the journal is English.

Copyright Notice
Turkish Journal of Cancer Research (TJCR) is the scientific publication of Academician Publishing. The Journal and its website are licensed to the Academician Publishing and all rights reserved ©.
The Academician Publishing currently provides Open Access to the website of the Journal. But, the articles, pictures, figures and tables published in Turkish Journal Cancer Research cannot be printed or reproduced partially or completely by any means without the written permission of the publisher. It can be summarized and quoted for scientific purposes with provided citing. The authors are responsible for the articles, figures and pictures published in the journal.
Any redistribution or reproduction of part or all of the contents in any form is prohibited other than the following:

you may print or download to a local hard disk extracts for your personal and non-commercial use only

you may copy the content to individual third parties for their personal use, but only if you acknowledge the website as the source of the material

You may not, except with our express written permission, distribute or commercially exploit the content. Nor may you transmit it or store it in any other website or other form of electronic retrieval system.
The concepts of access right and licensing are two totally different things:
Open Access means that all content is freely available without charge to the user or his/her institution on the principle that making research freely available to the public supports a greater global exchange of knowledge.
There are several types and levels of licensing models including free and commercial licenses. All kinds of special conditions may be included in a commercial license agreement.
A free license or open license is a license agreement which contains provisions that allow other individuals to reuse another creator's work, giving them four major freedoms. Without a special license, these uses are normally prohibited by copyright law or commercial license. Most free licenses are worldwide, royalty-free, non-exclusive, and perpetual. Free licenses are often the basis of crowdsourcing and crowdfunding projects.
For example; while GNU General Public License models are widely among software developers, Creative Commons copyright licenses are more widely used among digital artists, designers, and publishers. There may be several types of licenses for different purposes and providing different permission levels.
These conditions may include modification, distribute, remix, tweak, and build upon your work, commercially, or non- commercially.
As an example, the content of a website may be licensed under the terms of the Creative Commons Attribution (CC BY) License. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access. The Creative Commons Attribution License (CC BY) allows users to copy, distribute and transmit an article, adapt the article and make commercial use of the article. The CC BY license permits commercial and non-commercial re-use of an open access article, as long as the author is properly attributed.
Turkish Journal of Cancer Research (TJCR) requires the author as the rights holder to sign and submit the journal's agreement form during manuscript submission. The authors transfer all financial rights, especially processing, reproduction, representation, printing, distribution, and online transmittal to Academician Publishing with no limitation whatsoever, and grant Academician Publishing for its publication. This ensures both that Academician Publishing has the right to publish the article and that the author has confirmed various things including that it is their original work and that it is based on valid research.
Authors who publish with this journal agree to the following terms:
* Authors transfer copyright and grant the journal the right of processing, reproduction, representation, printing, distribution, and online transmittal to Academician Publishing with no limitation whatsoever, and grant Academician Publishing for its publication.
* Authors are not allowed to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., may not post it to an institutional repository or publish it in a book).
* Authors are not permitted to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process.

Article Processing Charge (APC)
Currently, Turkish Journal of Cancer Research charges no publication fee from the authors. The costs are covered by the academician publishing house. There are no charges for accepted and rejected articles, no submission charges, and no surcharges based on the length of an article, figures or supplementary data. The journal is intended to charge no publication fee as long as possible.

Journal Description

Turkish Journal of Cancer Research (TJCR) is the scientific publication of Academician Publishing, and Mediterranean Oncology Association is a partner to TJCR.
TJCR is published every three months and it is an online-only, peer-reviewed journal.
Turkish Journal of Cancer Research publishes original researches, case reports, editorial comments, reviews, letters to the editor in the fields of Basic and Clinical Oncology, Hematology, Radiation Oncology, Surgical Oncology, Gynecological Oncology, Radiology and Nuclear Medicine. The scientific language of the journal is English.
Manuscripts submitted for publication in the journal must comply with research and publication ethics. If the article sent to the journal complies with the formal principles, it will be published after the review of the editor and at least two advisors and, if necessary, the desired changes are made by the authors. All authors should have an academic-scientific direct contribution to the submitted article. The responsibility of the articles belongs to the authors

Article Submissions.
Manuscripts to be sent to the journal are made through the online article submission system of our journal, which is available at https://www.cancer-research.net. The articles to be sent outside the online application will not be evaluated. The articles sent to the journal are checked in terms of originality.

Editors and Contact:
Ali Murat Sedef, MD
Department of Medical Oncology, Tarsus Medicalpark Hospital, Mersin
E-mail: alimuratsedef@gmail.com

Ahmet Kürşad Güneş, MD
Department of Hematology, University of Health Sciences, Ankara City Hospital, Ankara
E-mail: khamog@hotmail.com

If You are Unable to Login Dashboard

Jun 11, 2020

Dear Authors,

If you have entered your journal username and password correctly but you are having trouble logging in to the journal panel, you need to clear your browser's cache. To troubleshoot the problem of being unable to log into the user dashboard, you should clear the browser cache by pressing CTRL + SHIFT + DELETE (COMMAND+SHIFT+BACKSPACE on a ) keys simultaneously in Google Chrome and Mozilla Firefox browsers, especially by selecting Cookies and Other Site Data option on the Clear Browsing Data screen.